XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ / shares in Thousands
Sep. 30, 2021
Dec. 31, 2020
Unrestricted cash and cash equivalents $ 166,966,000 $ 178,102,000
Restricted cash and cash equivalents 47,808,000 80,859,000
Loans, interest and fees receivable, at fair value 846,160,000 417,098,000
Loans, interest and fees receivable, gross 511,140,000 667,556,000
Allowances for uncollectible loans, interest and fees receivable 80,029,000 124,961,000
Deferred revenue 29,824,000 39,456,000
Notes payable, at face value $ 995,322,000 $ 882,610,000
Preferred stock, par value (in dollars per share) $ 0 $ 0
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, authorized (in shares) 150,000,000 150,000,000
Common stock, issued (in shares) 16,553,615 16,115,353
Common stock, outstanding (in shares) 15,094,382 16,115,353
Own-share lending arrangement, outstanding (in shares) 1,459,233 1,459,233
Treasury stock, shares (in shares) 1,459,233 0
Series A Preferred Stock [Member]    
Preferred stock, shares authorized (in shares) 10,000,000,000 10,000,000,000
Preferred stock, shares issued (in shares)   400,000
Preferred stock, shares outstanding (in shares) 400,000 400,000
Preferred stock, liquidation preference $ 40,000 $ 40,000
Series B Preferred Stock [Member]    
Preferred stock, no par value (in dollars per share) $ 0 $ 0
Preferred stock, shares issued (in shares) 3,188,533 0
Preferred stock, shares outstanding (in shares) 3,188,533 0
Preferred stock, liquidation preference $ 79,700,000 $ 79,700,000
Variable Interest Entity, Primary Beneficiary [Member]    
Unrestricted cash and cash equivalents 93,500,000 96,600,000
Restricted cash and cash equivalents 30,900,000 70,200,000
Loans, interest and fees receivable, at fair value 753,800,000 374,200,000
Loans, interest and fees receivable, gross 404,100,000 560,200,000
Allowances for uncollectible loans, interest and fees receivable 76,800,000 120,900,000
Deferred revenue 7,400,000 10,300,000
Notes payable, at face value $ 944,500,000 $ 827,100,000